BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37761908)

  • 21. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
    Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P
    Lancet Oncol; 2020 Nov; 21(11):1455-1464. PubMed ID: 33152285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A large-cohort retrospective study of metastatic patterns and prognostic outcomes between inflammatory and non-inflammatory breast cancer.
    Wang Z; Wang H; Ding X; Chen X; Shen K
    Ther Adv Med Oncol; 2020; 12():1758835920932674. PubMed ID: 32550867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prediction of distant metastasis risk for male breast cancer patients based on an interpretable machine learning model.
    Zhao X; Jiang C
    BMC Med Inform Decis Mak; 2023 Apr; 23(1):74. PubMed ID: 37085843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study.
    Sihto H; Lundin J; Lundin M; Lehtimäki T; Ristimäki A; Holli K; Sailas L; Kataja V; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
    Breast Cancer Res; 2011 Sep; 13(5):R87. PubMed ID: 21914172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age at diagnosis and distant metastasis in breast cancer--a surprising inverse relationship.
    Purushotham A; Shamil E; Cariati M; Agbaje O; Muhidin A; Gillett C; Mera A; Sivanadiyan K; Harries M; Sullivan R; Pinder SE; Garmo H; Holmberg L
    Eur J Cancer; 2014 Jul; 50(10):1697-1705. PubMed ID: 24768572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The curability of breast cancer and the treatment of advanced disease.
    Guarneri V; Conte PF
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S149-61. PubMed ID: 15107948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Nomogram for Predicting Liver Metastasis of Lymph-Node Positive Luminal B HER2 Negative Subtype Breast Cancer by Analyzing the Clinicopathological Characteristics of Patients with Breast Cancer.
    Yue Y; Liang J; Wu Y; Tong W; Li D; Cao X; Wang X
    Technol Cancer Res Treat; 2022; 21():15330338221132669. PubMed ID: 36254567
    [No Abstract]   [Full Text] [Related]  

  • 28. Breast carcinoma with an Oncotype Dx recurrence score <18: Rate of distant metastases in a large series with clinical follow-up.
    Wen HY; Krystel-Whittemore M; Patil S; Pareja F; Bowser ZL; Dickler MN; Norton L; Morrow M; Hudis CA; Brogi E
    Cancer; 2017 Jan; 123(1):131-137. PubMed ID: 27526056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ER
    Arciero CA; Guo Y; Jiang R; Behera M; O'Regan R; Peng L; Li X
    Clin Breast Cancer; 2019 Aug; 19(4):236-245. PubMed ID: 30846407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer.
    Rohan TE; Xue X; Lin HM; D'Alfonso TM; Ginter PS; Oktay MH; Robinson BD; Ginsberg M; Gertler FB; Glass AG; Sparano JA; Condeelis JS; Jones JG
    J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 24895374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis.
    Jung J; Lee SH; Park M; Youn JH; Shin SH; Gwak HS; Yoo H
    J Neurooncol; 2018 Apr; 137(2):295-302. PubMed ID: 29260362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status.
    Park YH; Lee S; Cho EY; Choi YL; Lee JE; Nam SJ; Yang JH; Ahn JS; Im YH
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):507-16. PubMed ID: 19956951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of metastasis and survival between male and female breast cancer with different molecular subtypes: A population-based observational study.
    Fang W; Huang Y; Han X; Peng J; Zheng M
    Cancer Med; 2022 Feb; 11(3):764-777. PubMed ID: 34898007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Machine learning on MRI radiomic features: identification of molecular subtype alteration in breast cancer after neoadjuvant therapy.
    Liu HQ; Lin SY; Song YD; Mai SY; Yang YD; Chen K; Wu Z; Zhao HY
    Eur Radiol; 2023 Apr; 33(4):2965-2974. PubMed ID: 36418622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set.
    Cain EH; Saha A; Harowicz MR; Marks JR; Marcom PK; Mazurowski MA
    Breast Cancer Res Treat; 2019 Jan; 173(2):455-463. PubMed ID: 30328048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors of distant metastasis after surgery among different breast cancer subtypes: a hospital-based study in Indonesia.
    Anwar SL; Avanti WS; Nugroho AC; Choridah L; Dwianingsih EK; Harahap WA; Aryandono T; Wulaningsih W
    World J Surg Oncol; 2020 May; 18(1):117. PubMed ID: 32473643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patterns of distant metastasis in Chinese women according to breast cancer subtypes.
    Wu SG; Sun JY; Yang LC; Tang LY; Wang X; Chen XT; Liu GH; Lin HX; Lin Q; He ZY
    Oncotarget; 2016 Jul; 7(30):47975-47984. PubMed ID: 27322074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
    Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients.
    Yamamura J; Kamigaki S; Fujita J; Osato H; Manabe H; Tanaka Y; Shinzaki W; Hashimoto Y; Komoike Y
    BMC Cancer; 2021 Apr; 21(1):476. PubMed ID: 33926418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.